Return On Equity in % of Clearside Biomedical, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Clearside Biomedical, Inc. quarterly/annual Return On Equity history and change rate from Q1 2017 to Q3 2025.
  • Clearside Biomedical, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 55.5 %, a 56.1% decline year-over-year.
  • Clearside Biomedical, Inc. annual Return On Equity for 2024 was 111 %, a 73.5% decline from 2023.
  • Clearside Biomedical, Inc. annual Return On Equity for 2023 was 419 %.
  • Clearside Biomedical, Inc. annual Return On Equity for 2022 was -153 %, a 9477% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Clearside Biomedical, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 55.5 -71 -56.1% 01 Jul 2025 30 Sep 2025
Q2 2025 65.9 -104 -61.2% 01 Apr 2025 30 Jun 2025
Q1 2025 83.4 -168 -66.9% 01 Jan 2025 31 Mar 2025
Q4 2024 111 -308 -73.5% 01 Oct 2024 31 Dec 2024
Q3 2024 127 -3.18K -96.2% 01 Jul 2024 30 Sep 2024
Q2 2024 170 +704 01 Apr 2024 30 Jun 2024
Q1 2024 252 +494 01 Jan 2024 31 Mar 2024
Q4 2023 419 +572 01 Oct 2023 31 Dec 2023
Q3 2023 3.31K +3.32K 01 Jul 2023 30 Sep 2023
Q2 2023 -534 -528 -9106% 01 Apr 2023 30 Jun 2023
Q1 2023 -242 -243 -78078% 01 Jan 2023 31 Mar 2023
Q4 2022 -153 -155 -9477% 01 Oct 2022 31 Dec 2022
Q3 2022 -16.1 +146 +90% 01 Jul 2022 30 Sep 2022
Q2 2022 -5.8 +167 +96.6% 01 Apr 2022 30 Jun 2022
Q1 2022 0.31 +220 01 Jan 2022 31 Mar 2022
Q4 2021 1.63 +212 01 Oct 2021 31 Dec 2021
Q3 2021 -162 -8.31 -5.42% 01 Jul 2021 30 Sep 2021
Q2 2021 -173 +16.6 +8.74% 01 Apr 2021 30 Jun 2021
Q1 2021 -220 -54.9 -33.3% 01 Jan 2021 31 Mar 2021
Q4 2020 -210 +36.2 +14.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -153 +163 +51.5% 01 Jul 2020 30 Sep 2020
Q2 2020 -189 +86.3 +31.3% 01 Apr 2020 30 Jun 2020
Q1 2020 -165 +51.8 +23.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -247 -96.2 -64% 01 Oct 2019 31 Dec 2019
Q3 2019 -316 -174 -122% 01 Jul 2019 30 Sep 2019
Q2 2019 -276 -139 -102% 01 Apr 2019 30 Jun 2019
Q1 2019 -217 -85.6 -65.2% 01 Jan 2019 31 Mar 2019
Q4 2018 -150 -19.2 -14.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -142 -51.8 -57.1% 01 Jul 2018 30 Sep 2018
Q2 2018 -137 -71.1 -108% 01 Apr 2018 30 Jun 2018
Q1 2018 -131 -78.2 -147% 01 Jan 2018 31 Mar 2018
Q4 2017 -131 01 Oct 2017 31 Dec 2017
Q3 2017 -90.7 01 Jul 2017 30 Sep 2017
Q2 2017 -65.8 01 Apr 2017 30 Jun 2017
Q1 2017 -53.2 01 Jan 2017 31 Mar 2017

Clearside Biomedical, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 111 -308 -73.5% 01 Jan 2024 31 Dec 2024
2023 419 +572 01 Jan 2023 31 Dec 2023
2022 -153 -155 -9477% 01 Jan 2022 31 Dec 2022
2021 1.63 +212 01 Jan 2021 31 Dec 2021
2020 -210 +36.2 +14.7% 01 Jan 2020 31 Dec 2020
2019 -247 -96.2 -64% 01 Jan 2019 31 Dec 2019
2018 -150 -19.2 -14.6% 01 Jan 2018 31 Dec 2018
2017 -131 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.